MIRM NASDAQ
Mirum Pharmaceuticals, Inc.
1W: -7.5%
1M: -16.9%
3M: -32.0%
YTD: +6.2%
1Y: +13.6%
3Y: +169.2%
5Y: +348.5%
$82.93
-0.99 (-1.18%)
Weekly Expected Move ±5.0%
$75
$79
$83
$87
$91
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.1B
52W Range63.23-130
Volume1,134,037
Avg Volume770,856
Beta0.49
Dividend—
Analyst Ratings
Company Info
CEOChristopher Peetz
Employees433
SectorHealthcare
IndustryBiotechnology
IPO Date2019-07-18
Websitemirumpharma.com
989 East Hillsdale Boulevard
Foster City, CA 94404
US
Foster City, CA 94404
US
650 667 4085
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Latest News
Mirum's Brelovitug Meets Goal in Phase III AZURE-1 Study in HDV
MIRM Stock Gets Increased EPS Forecast from HC Wainwright
Mirum wins FDA approval for Atebrioz
Mirum falls despite meeting primary goal in phase 3 brelovitug study for hepatitis D
MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Myers Robert Paul | 0 | — | 2026-09-21 | |
| BJERKHOLT ERIC | S-Sale | 9,943 | $98.37 | 2026-09-14 |
| BJERKHOLT ERIC | M-Exempt | 18,333 | — | 2026-09-11 |
| BJERKHOLT ERIC | M-Exempt | 18,333 | — | 2026-09-11 |
| Howe Jolanda | S-Sale | 658 | $100.00 | 2026-09-02 |